DZIP1L

Chr 3AR

DAZ interacting zinc finger protein 1 like

Also known as: DZIP2, PKD5

Predicted to enable zinc ion binding activity. Involved in cilium assembly and regulation of protein localization. Located in several cellular components, including intercellular bridge; microtubule cytoskeleton; and nucleoplasm. Implicated in polycystic kidney disease 5. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 1.301 OMIM phenotype
Clinical SummaryDZIP1L
🧬
Gene-Disease Validity (ClinGen)
autosomal recessive polycystic kidney disease · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
18 unique Pathogenic / Likely Pathogenic· 157 VUS of 327 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.30LOEUF
pLI 0.000
Z-score 0.06
OE 0.99 (0.761.30)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.10Z-score
OE missense 0.99 (0.911.07)
430 obs / 435.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.99 (0.761.30)
00.351.4
Missense OE?0.99 (0.911.07)
00.61.4
Synonymous OE?0.96
01.21.6
LoF obs/exp: 38 / 38.4Missense obs/exp: 430 / 435.9Syn Z: 0.39

This gene — mechanism propensity

DN
0.6357th %ile
GOF
0.6540th %ile
LOF
0.3939th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

327 submitted variants in ClinVar

Classification Summary

Pathogenic11
Likely Pathogenic7
VUS157
Likely Benign90
Benign39
Conflicting5
11
Pathogenic
7
Likely Pathogenic
157
VUS
90
Likely Benign
39
Benign
5
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
9
1
1
0
11
Likely Pathogenic
6
1
0
0
7
VUS
4
145
8
0
157
Likely Benign
0
12
35
43
90
Benign
0
14
21
4
39
Conflicting
5
Total191736547309

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

19 pathogenic / likely-pathogenic (of 23) ClinVar copy-number / structural variants overlap DZIP1L — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

DZIP1L · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →